We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.66%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.03B
AUM Growth
+$1.87B
(+26%)
Cap. Flow
+$1.68B
Cap. Flow
% of AUM
18.63%
Top 10 Holdings %
Top 10 Hldgs %
13.82%
Holding
1,787
New
329
Increased
1,367
Reduced
42
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$58.9M |
| 2 |
Microsoft
MSFT
|
+$45.4M |
| 3 |
Amazon
AMZN
|
+$30.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$28.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$2M |
| 2 |
ProShares Merger ETF
MRGR
|
+$1.93M |
| 3 |
Alcoa
AA
|
+$1.78M |
| 4 |
RALS
ProShares RAFI Long/Short
RALS
|
+$1.32M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.42% |
| 2 | Healthcare | 14.55% |
| 3 | Technology | 12.09% |
| 4 | Consumer Staples | 11.44% |
| 5 | Industrials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HI
1151
DELISTED
Hillenbrand
HI
| $430K | ﹤0.01% |
11,209
+3,849
| +52% | +$130K |
|
1152
New York Times
NYT
$11.7B
| $430K | ﹤0.01% |
32,305
+9,868
| +44% | +$122K |
|
1153
Edgewell Personal Care
EPC
$1.27B
| $429K | ﹤0.01% |
5,882
+977
| +20% | +$75.5K |
|
|
RDC
1154
DELISTED
Rowan Companies Plc
RDC
| $429K | ﹤0.01% |
22,697
+3,414
| +18% | +$55.7K |
|
|
MACK
1155
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $429K | ﹤0.01% |
13,375
+1,493
| +13% | +$63.7K |
|
|
FLXN
1156
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $427K | ﹤0.01% |
22,476
+2,826
| +14% | +$54K |
|
1157
Carter's
CRI
$1.41B
| $426K | ﹤0.01% |
4,932
+851
| +21% | +$76K |
|
1158
Mueller Industries
MLI
$14.1B
| $426K | ﹤0.01% |
42,688
+14,776
| +53% | +$130K |
|
1159
MSC Industrial Direct
MSM
$7.03B
| $425K | ﹤0.01% |
4,598
+871
| +23% | +$71.8K |
|
1160
Bio-Rad Laboratories Class A
BIO
$8.41B
| $424K | ﹤0.01% |
2,326
+382
| +20% | +$65.1K |
|
|
PKY
1161
DELISTED
Parkway, Inc.
PKY
| $423K | ﹤0.01% |
+19,030
| New | +$360K |
|
1162
Core Laboratories
CLB
$539M
| $421K | ﹤0.01% |
3,505
+388
| +12% | +$43K |
|
1163
MasTec
MTZ
$27.1B
| $421K | ﹤0.01% |
11,004
+4,096
| +59% | +$139K |
|
|
EFII
1164
DELISTED
Electronics for Imaging
EFII
| $421K | ﹤0.01% |
9,594
+3,285
| +52% | +$144K |
|
|
UCB
1165
United Community Banks
UCB
$4.23B
| $420K | ﹤0.01% |
+14,187
| New | +$355K |
|
|
PSB
1166
DELISTED
PS Business Parks, Inc.
PSB
| $420K | ﹤0.01% |
3,602
+1,268
| +54% | +$139K |
|
1167
Cinemark Holdings
CNK
$3.85B
| $419K | ﹤0.01% |
10,919
+1,875
| +21% | +$74.6K |
|
|
ARAV
1168
DELISTED
Aravive, Inc. Common Stock
ARAV
| $418K | ﹤0.01% |
4,670
+1,116
| +31% | +$84.6K |
|
|
ROIC
1169
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $417K | ﹤0.01% |
19,715
+6,932
| +54% | +$142K |
|
|
DNR
1170
DELISTED
Denbury Resources, Inc.
DNR
| $416K | ﹤0.01% |
113,088
+28,019
| +33% | +$90.1K |
|
1171
Inovio Pharmaceuticals
INO
$80.6M
| $414K | ﹤0.01% |
4,966
+556
| +13% | +$50.3K |
|
|
WFT
1172
DELISTED
Weatherford International plc
WFT
| $414K | ﹤0.01% |
83,053
+14,607
| +21% | +$76.4K |
|
1173
Allegiant Air
ALGT
$2.63B
| $413K | ﹤0.01% |
2,479
+844
| +52% | +$132K |
|
1174
First Solar
FSLR
$21.8B
| $413K | ﹤0.01% |
12,871
-8,789
| -41% | -$308K |
|
1175
NRG Energy
NRG
$29.6B
| $413K | ﹤0.01% |
33,718
-26,922
| -44% | -$310K |
|
Similar funds
ProShare Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, ProShare Advisors held 1,787 positions worth $9.03B, up 26% from $7.16B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors deployed $1.68B of net new capital in Q4 2016, opening 329 new positions and adding to 1,367 existing holdings. Its largest new stake was Opko Health: 373,523 shares worth $3.47M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Linear Technology Corp, an estimated $2M trimmed.
- ProShare Advisors's largest Q4 2016 buy was Opko Health: 373,523 shares worth $3.47M.
- ProShare Advisors added most to Apple in Q4 2016, an estimated $58.9M increase.
- ProShare Advisors's biggest Q4 2016 reduction was Linear Technology Corp, cutting an estimated $2M.
- ProShare Advisors fully exited Post Properties in Q4 2016, selling an estimated $1.06M.
- ProShare Advisors's ten largest holdings make up 14% of its $9.03B portfolio in Q4 2016.
- ProShare Advisors opened 329 new positions and closed 46 in Q4 2016.
- ProShare Advisors's portfolio value rose 26% quarter-over-quarter to $9.03B.
Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.